Berezin alexander e (57 résultats)

PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000.

Etat : New.

PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000.

Etat : New.

Etat : New. In.

PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000.

PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000.

Etat : New.

Etat : New.

Etat : New.

PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000.

PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000.

Paperback. Etat : Brand New. 80 pages. 8.66x5.91x0.19 inches. In Stock.

Etat : Buono (Good). 7 Yury Balanenko e Alexander Berezin Moscow. Yury Balanenko e Alexander Berezin. Planeta Publishers 1975. Mosca, Planeta Publishers 1975 - I english, in quarto pp.208 23457Yury Balanenko e Alexander Berezin.MoscowPlaneta Publishers- 1975In lingua inglese tradotto da Galina Strelkova, Victoria MaslesinaLibro fotografico dedicato alla capitale russa. Pagine leggermente ingiallite. Copertina cartonata in similtela.Manca la sovracoperta. Book.…

Taschenbuch. Etat : Neu. Contemporary approaches of biological markers in heart failure | New dawn in the individualized care | Alexander E. Berezin | Taschenbuch | 80 S. | Englisch | 2017 | Scholars' Press | EAN 9783330653733 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.…

Etat : New. In.

Etat : New. In.

Etat : New. In.

Taschenbuch. Etat : Neu. Approches contemporaines des marqueurs biologiques dans l'insuffisance cardiaque | L'aube d'une prise en charge individualisée | Alexander E. Berezin | Taschenbuch | Französisch | 2024 | Editions Notre Savoir | EAN 9786208164799 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.…

Taschenbuch. Etat : Neu. Approcci contemporanei ai marcatori biologici nello scompenso cardiaco | Una nuova alba nella cura personalizzata | Alexander E. Berezin | Taschenbuch | Italienisch | 2024 | Edizioni Sapienza | EAN 9786208164812 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. …

Taschenbuch. Etat : Neu. Abordagens contemporâneas dos marcadores biológicos na insuficiência cardíaca | Nova aurora nos cuidados individualizados | Alexander E. Berezin | Taschenbuch | Portugiesisch | 2024 | Edições Nosso Conhecimento | EAN 9786208164829 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu.…

Taschenbuch. Etat : Neu. Moderne Ansätze biologischer Marker bei Herzinsuffizienz | Neue Wege in der individualisierten Versorgung | Alexander E. Berezin | Taschenbuch | 84 S. | Deutsch | 2024 | Verlag Unser Wissen | EAN 9786208164775 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu. …

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Biomarkers are deeply incorporated into up-to-date clinical guidelines for acute, acutely decompensated and chronic heart failure. According to contemporary evaluation of efficacy of medical care in disease management, cardiac biomarkers are recognized an individual probes that are suitable for stratification of individuals at risk of hea development and progression, improving heart failure prevention, and target-to-treat heart failure therapy. There is a large body of evidence regarding the limiting role of biomarker as predictive tool in heart failure management. Lots of sophisticated biomarker predictive scores have now created to attenuate heart failure risk prognostication, there was not received strong evidence that all these are equal on their ability to predict clinical outcomes and death in patients with different phenotypes of HF, across all pathophysiological stages of heart failure, at acute and chronic HF and even in heart failure patients with several co-morbidities, various ages and ethnicities. 80 pp. Englisch.…

Etat : New. Print on Demand.

Etat : New. PRINT ON DEMAND.

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 84 pp. Spanisch.

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Berezin Alexander E.Alexander E. Berezin is currently Professor (full)of Medicine, Senior Consultant of Cardiology Unit of InternalMedicine Department at State Medical University, Zaporozhye, Ukraine.His research goals are fundamenta.…

Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Biomarkers are deeply incorporated into up-to-date clinical guidelines for acute, acutely decompensated and chronic heart failure. According to contemporary evaluation of efficacy of medical care in disease management, cardiac biomarkers are recognized an individual probes that are suitable for stratification of individuals at risk of hea development and progression, improving heart failure prevention, and target-to-treat heart failure therapy. There is a large body of evidence regarding the limiting role of biomarker as predictive tool in heart failure management. Lots of sophisticated biomarker predictive scores have now created to attenuate heart failure risk prognostication, there was not received strong evidence that all these are equal on their ability to predict clinical outcomes and death in patients with different phenotypes of HF, across all pathophysiological stages of heart failure, at acute and chronic HF and even in heart failure patients with several co-morbidities, various ages and ethnicities.…

Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Biomarkers are deeply incorporated into up-to-date clinical guidelines for acute, acutely decompensated and chronic heart failure. According to contemporary evaluation of efficacy of medical care in disease management, cardiac biomarkers are recognized an individual probes that are suitable for stratification of individuals at risk of hea development and progression, improving heart failure prevention, and target-to-treat heart failure therapy. There is a large body of evidence regarding the limiting role of biomarker as predictive tool in heart failure management. Lots of sophisticated biomarker predictive scores have now created to attenuate heart failure risk prognostication, there was not received strong evidence that all these are equal on their ability to predict clinical outcomes and death in patients with different phenotypes of HF, across all pathophysiological stages of heart failure, at acute and chronic HF and even in heart failure patients with several co-morbidities, various ages and ethnicities.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 80 pp. Englisch.…

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 84 pp. Französisch.